Pesquisar | Soocian

Pratiksha Chokhande adicionou um novo artigo Health
2026-06-16 06:53:27 -

Dextromethorphan Market Assessment and Competitive Analysis Report
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to...

1

0 Comentários 1 Compartilhamentos 378 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Pratiksha Chokhande adicionou um novo artigo Health
2026-06-04 05:04:32 -

Dextromethorphan Market Growth Opportunities and Industry Trends Analysis
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to 2030....

0 Comentários 0 Compartilhamentos 188 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Pratiksha Chokhande adicionou um novo artigo Health
2026-07-30 10:07:44 -

Dextromethorphan Market Report: Size, Share, Trends & Forecast to 2033
"Dextromethorphan Market Summary According to the latest report published by Data Bridge Market Research, the Dextromethorphan Market Data Bridge Market Research analyses that the global dextromethorphan market which was USD 487.25 million in 2022, is expected to reach USD 587.31 million by 2030, and is expected to undergo a CAGR of 4.8% during the forecast period of 2023 to 2030. An...

0 Comentários 0 Compartilhamentos 249 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Surbhi Verma adicionou um novo artigo Health
2026-07-24 11:05:22 -

Pseudobulbar Treatment Market: How Is Dextromethorphan-Quinidine Fixed-Dose Therapy Becoming the Fastest-Growing Pharmacological Standard?
Dextromethorphan-quinidine fixed-dose combination (Nuedexta, Avanir/Otsuka) — the first FDA-approved therapy specifically indicated for pseudobulbar affect (PBA) in amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) patients, modulating glutamatergic and sigma-1 receptor signaling while inhibiting CYP2D6 metabolism — creates the most commercially dynamic market segment,...

0 Comentários 0 Compartilhamentos 345 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!